Market
Will Oracle develop an AI-powered mRNA cancer vaccine prototype by end of 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Official press release or announcement from Oracle
Story
Oracle's Larry Ellison Envisions AI-Powered mRNA Cancer Vaccines in 48 Hours at White House
Jan 22, 2025, 07:37 AM
Oracle Corp. CEO Larry Ellison has outlined a future where artificial intelligence (AI) will revolutionize cancer treatment by enabling the design and robotic production of personalized mRNA vaccines within 48 hours. Speaking at the White House during an announcement on Project Starship, Ellison highlighted that AI could detect early-stage cancer through blood tests and subsequently develop tailored mRNA vaccine therapies. He emphasized the potential of AI in healthcare, stating, 'This is the promise of AI.' The initiative involves collaboration with tools provided by Sam and Masa, though specific details about these tools were not disclosed.
View original story
Similar markets
No • 50%
Yes • 50%
Moderna • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Moderna • 25%
Other • 25%
BioNTech • 25%
Pfizer • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Breast Cancer • 25%
Prostate Cancer • 25%
Other • 25%
Lung Cancer • 25%
Oracle • 25%
Moderna • 25%
Other • 25%
Pfizer • 25%